1 min read

WEBINAR: Excellence In Anti-Idiotype Antibody Discovery

10/28/19 6:29 PM

Date: November 13, 2019 at 2PM ET (11AM PT)
TraceyMullenPlease join Abveris' Chief Operating Officer, Tracey Mullen, for our webinar to learn more about our premier anti-idiotype antibody discovery service for mAbs, bispecifics, scFvs, VHHs, and more.

Benefits of our approach:
  • Rapid reagent generation timelines
  • Maximal epitope coverage with DiversimAb technology
  • Highly sensitive specificity screening
  • Identification of high-affinity mAbs
  • Neutralizing and non-neutralizing mAbs
  • Flexible deliverable strategies
  • All work done in the USA

Abveris has the expertise and technology advantages required to develop high-quality reagents to the trickiest biotherapeutic molecules. Join our webinar to learn more.
Interested, but have a scheduling conflict? Click here to register and a video link will be sent after the webinar finishes. 

 

CLICK HERE TO DOWNLOAD OUR  ANTI-IDIOTYPE PRICING SHEET

 

CLICK HERE TO DOWNLOAD OUR  ANTI-IDIOTYPE PRICING SHEET

 

 

Travis LeGuyader

Written by Travis LeGuyader

Featured